Active specific immunotherapy: Using tumor heterogeneity to successfully fight cancer

Michael G Hanna; Jason Howard; Jan Vermorken

doi:10.4161/hv.28886

Active specific immunotherapy: Using tumor heterogeneity to successfully fight cancer

Human Vaccines & Immunotherapeutics ◽

10.4161/hv.28886 ◽

2014 ◽

Vol 10 (11) ◽

pp. 3286-3296 ◽

Cited By ~ 1

Author(s):

Michael G Hanna ◽

Jason Howard ◽

Jan Vermorken

Keyword(s):

Tumor Heterogeneity ◽

Specific Immunotherapy ◽

Active Specific Immunotherapy

Download Full-text

Therapeutic benefit of adjuvant active specific immunotherapy (A.S.I.) with autologous tumor-vaccines in patients with colon cancer. Results of a randomised fase III study

Immunology Letters ◽

10.1016/s0165-2478(97)87692-4 ◽

1997 ◽

Vol 56 (1-3) ◽

pp. 214

Author(s):

A Claessen

Keyword(s):

Colon Cancer ◽

Specific Immunotherapy ◽

Therapeutic Benefit ◽

Autologous Tumor ◽

Tumor Vaccines ◽

Active Specific Immunotherapy

Download Full-text

Treatment of minimal tumor load in locally advanced renal cell carcinoma by active specific immunotherapy (ASI) with autologous virus modified tumor vaccines

Journal of Cancer Research and Clinical Oncology ◽

10.1007/bf02572053 ◽

1995 ◽

Vol 121 (S1) ◽

pp. A22-A22

Author(s):

A. Hinkel ◽

W. de Riese ◽

F. W. Falkenberg ◽

J. Pastor ◽

Th. Senge

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Renal Cell ◽

Specific Immunotherapy ◽

Locally Advanced ◽

Advanced Renal Cell Carcinoma ◽

Tumor Vaccines ◽

Active Specific Immunotherapy ◽

Tumor Load

Download Full-text

Active specific immunotherapy with extracted tumor-specific transplantation antigen, cyclophosphamide, and adoptive transfer of tumor-specific cytotoxic T-cell clones

Cellular Immunology ◽

10.1016/0008-8749(88)90065-2 ◽

1988 ◽

Vol 111 (1) ◽

pp. 216-234 ◽

Cited By ~ 3

Author(s):

Kazuyo Naito ◽

Neal R. Pellis ◽

Barry D. Kahan

Keyword(s):

T Cell ◽

Adoptive Transfer ◽

Specific Immunotherapy ◽

Cytotoxic T Cell ◽

Transplantation Antigen ◽

T Cell Clones ◽

Active Specific Immunotherapy ◽

Cell Clones

Download Full-text

Validity of combination active specific immunotherapy for colorectal cancer: a meta-analysis of 2993 patients

Cytotherapy ◽

10.1016/j.jcyt.2015.08.009 ◽

2015 ◽

Vol 17 (12) ◽

pp. 1746-1762 ◽

Cited By ~ 2

Author(s):

Jun-Xia Cao ◽

Xiao-Yan Zhang ◽

Jin-Long Liu ◽

Jun-Li Li ◽

Yi-Shan Liu ◽

...

Keyword(s):

Colorectal Cancer ◽

Specific Immunotherapy ◽

Meta Analysis ◽

Active Specific Immunotherapy

Download Full-text

A Phase II Prospective Multi-institutional Trial of Adjuvant Active Specific Immunotherapy Following Curative Resection of Colorectal Cancer Hepatic Metastases: Cancer and Leukemia Group B Study 89903

Annals of Surgical Oncology ◽

10.1245/s10434-007-9654-7 ◽

2007 ◽

Vol 15 (1) ◽

pp. 158-164 ◽

Cited By ~ 26

Author(s):

Mitchell C. Posner ◽

Donna Niedzwiecki ◽

Alan P. Venook ◽

Donna R. Hollis ◽

Hedy L. Kindler ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Curative Resection ◽

Specific Immunotherapy ◽

Hepatic Metastases ◽

Active Specific Immunotherapy ◽

Group B ◽

Leukemia Group

Download Full-text

Immunotherapy for malignant gliomas: emphasis on strategies of active specific immunotherapy using autologous dendritic cells

Child s Nervous System ◽

10.1007/s00381-004-0994-3 ◽

2004 ◽

Vol 21 (1) ◽

pp. 7-18 ◽

Cited By ~ 16

Author(s):

Steven De Vleeschouwer ◽

Stefaan W. Van Gool ◽

Frank Van Calenbergh

Keyword(s):

Dendritic Cells ◽

Specific Immunotherapy ◽

Malignant Gliomas ◽

Active Specific Immunotherapy

Download Full-text

Ga733/EpCAM as a Target for Passive and Active Specific Immunotherapy in Patients with Colorectal Carcinoma

Annals of the New York Academy of Sciences ◽

10.1111/j.1749-6632.2000.tb06713.x ◽

2006 ◽

Vol 910 (1) ◽

pp. 254-262 ◽

Cited By ~ 12

Author(s):

H. MELLSTEDT ◽

J. FAGERBERG ◽

J-E. FRÖDIN ◽

A-L. HJELM-SKOG ◽

M. LILJEFORS ◽

...

Keyword(s):

Colorectal Carcinoma ◽

Specific Immunotherapy ◽

Active Specific Immunotherapy

Download Full-text

Latest Advances in the Understanding of Active-Specific Immunotherapy for Brain Tumors

ACS Symposium Series - Controlled Drug Delivery ◽

10.1021/bk-2000-0752.ch022 ◽

2000 ◽

pp. 220-229

Author(s):

Yang Liu ◽

Qingzhong Kong ◽

Ka-yun Ng ◽

Kevin Lillehei

Keyword(s):

Brain Tumors ◽

Specific Immunotherapy ◽

Active Specific Immunotherapy

Download Full-text

The Anti-Idiotypic Approach to Active Specific Immunotherapy of Malignant Melanoma

Idiotypes in Medicine: Autoimmunity, Infection and Cancer ◽

10.1016/b978-044482807-1/50050-8 ◽

1997 ◽

pp. 523-536 ◽

Cited By ~ 1

Author(s):

Xinhui Wang ◽

Smruti Desai ◽

Elvyra J. Noronha ◽

Abraham Mittelman ◽

Soldano Ferrone

Keyword(s):

Malignant Melanoma ◽

Specific Immunotherapy ◽

Active Specific Immunotherapy

Download Full-text

Active, Specific Immunotherapy with Autologous Tumor Cells Admixed with Corynebacterium Parvum in Patients with Metastatic Renal Cell Carcinoma

Present Status of Non-Toxic Concepts in Cancer ◽

10.1159/000413715 ◽

2015 ◽

pp. 221-236

Author(s):

K. H. Kurth ◽

R. Marquet ◽

J. Zwartendijk ◽

S. O. Warnaar

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Tumor Cells ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Specific Immunotherapy ◽

Autologous Tumor ◽

Corynebacterium Parvum ◽

Active Specific Immunotherapy

Download Full-text